- Journal of Immunology and Clinical Microbiology
- Vol: 6 Issue: 3
- Treatment Combinations and Prognosis in Multiple Resistant Acinetobacter baumannii and Carbapenem Re...
Treatment Combinations and Prognosis in Multiple Resistant Acinetobacter baumannii and Carbapenem Resistant Klebsiella pneumonıae/oxytoca Isolates
Authors : Ahmet DOĞAN, Yakup GEZER
Pages : 121-128
View : 8 | Download : 2
Publication Date : 2021-10-30
Article Type : Research
Abstract :Multi-drug-resistant (MDR) gram-negative bacterial infections are one of the most important causes of prolonged hospitalization and mortality in patients followed up in the İntensive Care Unit (ICU). In our study, we retrospectively scanned the blood and tracheal aspirate cultures (TAC) of patients hospitalized in the ICUs of our hospital. We investigated the effects of demographic characteristics, comorbid conditions, treatment combinations and time of treatment on survival of 83 patients with MDR Acinetobacter baumannii and Klepsiella pneumoniae/oxytoca strains in culture samples from 450 cases. Of the patients, 48 (57.83%) were male, and 35 (42.17%) were female. Of all cases, the average age (years) was average±SD (Min-Max), 76.24±13 (23-96). Length of stay in intensive care, the average (day) was 25.61±19.1 (1-107). Cerebrovascular Dısease (CVD) was the most common (20%) comorbidity. A. baumannii was grown in 31 (37.3%) patients, K. pneumoniae was grown in 50 (60.3%) patients, and K. oxytoca was grown in 2 (2.4%) patients. Age (p=0.793), sex (p=0.429), length of hospital stay (p=0.097), number of comorbidities (p=0.553), treatment combinations (p=0.727), pathogen type (p=0.622), growth in blood culture and/or TAC (p=0.369), there was no statistically significant difference indicating that factors such as increased mortality. It was observed that intubation (p=0.004) and duration of treatment of 7 days or less (p=0.001) significantly reduced survival. In the treatment of MDR Acınetobacter and Klebsıella, ıntubatıon and duratıon of treatment affected survıval, but than combınatıon.Keywords : multiple resistance, carbapenem resistant, acinetobacter baumannii, klebsiella pneumoniae/oxytoca, colimycin, tigecycline